Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

21 Nov 2024

Abstract excerpt

Diffuse Large B-cell Lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL). Despite the use of newer agents, such as polatuzumab vedotin, more than one-third of patients have ultimately relapsed or experienced refractory disease. MiRNAs are single-stranded, ~22-nucleotide-long RNAs that interact with their target RNA. They are significant regulators of post-transcriptional gene expression. One...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39767565
DOI: 10.3390/biomedicines12122658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell LymphomaPMID 39767565Read ↗

The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaSemantic proximity Read ↗

microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell LymphomaSemantic proximity Read ↗

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemiaSemantic proximity Read ↗

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas.Semantic proximity Read ↗

Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)Semantic proximity Read ↗

Non-Coding RNAs in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphomaSemantic proximity Read ↗

MicroRNAs in lymphoma, from diagnosis to targeted therapySemantic proximity Read ↗

Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressionsSemantic proximity Read ↗

Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.Semantic proximity Read ↗

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.